Berman, Ellin

Publications

Sort by

Co-Author Network

selected publications

Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study. The Journal of infection. 2018 Academic Article GET IT
Times cited: 33
Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia. Leukemia research. 2018 Academic Article GET IT
Times cited: 2
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leukemia research. 2016 Academic Article GET IT
Times cited: 31
Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation. Leukemia research. 2015 Academic Article GET IT
Times cited: 5
FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia. 2015 Academic Article GET IT
Times cited: 62
Chronic myelogenous leukemia, version 1.2015. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 43
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood. 2014 Academic Article GET IT
Times cited: 106
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature. 2014 Academic Article GET IT
Times cited: 426
Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors. Leukemia research. 2013 Academic Article GET IT
Times cited: 22
Genetic mutations in chronic myelogenous leukemia: when to check and what to do?. Current opinion in hematology. 2012 Information Resource GET IT
Times cited: 1
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia. Blood. 2011 Academic Article GET IT
Times cited: 104
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2011 Academic Article GET IT
Times cited: 39
Omacetaxine: the FDA decision. Clinical advances in hematology & oncology : H&O. 2011 Academic Article GET IT
Times cited: 8
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia. Blood. 2010 Academic Article GET IT
Times cited: 136
Imatinib and altered bone and mineral metabolism. The New England journal of medicine. 2006 Article GET IT
Times cited: 16
Altered bone and mineral metabolism in patients receiving imatinib mesylate. The New England journal of medicine. 2006 Academic Article GET IT
Times cited: 232
Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy. Cancer. 2002 Academic Article GET IT
Times cited: 5
Recent advances in the treatment of acute leukemia: 1999. Current opinion in hematology. 2000 Information Resource GET IT
Times cited: 13
Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL). Leukemia research. 2000 Academic Article GET IT
Times cited: 8
Recent advances in the treatment of acute leukemia. Current opinion in hematology. 1997 Information Resource GET IT
Times cited: 4
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Leukemia. 1996 Academic Article GET IT
Times cited: 32
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia. Leukemia. 1996 Academic Article GET IT
Times cited: 22
Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia. Leukemia. 1995 Academic Article GET IT
Times cited: 50
Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood. 1995 Academic Article GET IT
Times cited: 119
A phase II study of continuous infusion of trimetrexate in patients with refractory acute leukemia. Cancer investigation. 1995 Academic Article GET IT
Times cited: 10
Chemotherapy in acute myelogenous leukemia: high dose, higher expectations?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Editorial Article GET IT
Times cited: 21
Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia. Leukemia. 1994 Academic Article GET IT
Times cited: 50
Comparative activity of tamoxifen and N-desmethyltamoxifen in human multidrug resistant leukemia cell lines. Leukemia. 1994 Academic Article GET IT
Times cited: 8
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation. American journal of hematology. 1994 Academic Article GET IT
Times cited: 7
All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Annals of internal medicine. 1994 Academic Article GET IT
Times cited: 262
A review of idarubicin in acute leukemia. Oncology (Williston Park, N.Y.). 1993 Information Resource GET IT
Times cited: 25
Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia. Leukemia. 1993 Academic Article GET IT
Times cited: 19
Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood. 1992 Academic Article GET IT
Times cited: 72
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow. Bone marrow transplantation. 1992 Academic Article GET IT
Times cited: 32
Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells. Blood. 1992 Academic Article GET IT
Times cited: 166
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia. Seminars in oncology. 1992 Academic Article GET IT
Times cited: 20
New drugs in acute myelogenous leukemia: a review. Journal of clinical pharmacology. 1992 Information Resource GET IT
Times cited: 9
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood. 1992 Academic Article GET IT
Times cited: 67
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. The New England journal of medicine. 1992 Academic Article GET IT
Times cited: 48
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood. 1991 Academic Article GET IT
Times cited: 355
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 215
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood. 1991 Academic Article GET IT
Times cited: 76
Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC). Leukemia & lymphoma. 1991 Academic Article GET IT
Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies. Haematologica. 1990 Information Resource GET IT
Times cited: 42
Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a. Blood. 1990 Academic Article GET IT
Times cited: 92
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Haematology and blood transfusion. 1990 Information Resource GET IT
Times cited: 28
Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells. Blood. 1989 Academic Article GET IT
Times cited: 41
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol. Leukemia. 1989 Academic Article GET IT
Times cited: 38
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Seminars in oncology. 1989 Academic Article GET IT
Times cited: 29
4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia. Cancer research. 1989 Academic Article GET IT
Times cited: 21
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 7
Idarubicin in acute leukemia: results of US trials. Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 3
Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC). Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 2
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 148
Diagnosis and monitoring in patients with hairy cell leukemia using the monoclonal antibody anti-HC2. Leukemia. 1987 Academic Article GET IT
Times cited: 5
Hairy cell leukemia: a model for studying the B cell family of diseases. Seminars in oncology. 1986 Academic Article GET IT
Times cited: 2
Regulation of the proliferation of the established human monoblast cell line, U937, at the single cell level. Cancer research. 1986 Academic Article GET IT
Times cited: 4
Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin. Experimental hematology. 1986 Academic Article GET IT
Times cited: 5
Gamma interferon induces colony-forming cells of the human monoblast cell line U937 to respond to inhibition by lactoferrin, transferrin, and acidic isoferritins. Experimental hematology. 1986 Academic Article GET IT
Times cited: 10
Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 144
Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone. Cancer chemotherapy and pharmacology. 1986 Academic Article GET IT
Times cited: 4
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 8
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer. Cancer research. 1983 Academic Article GET IT
Times cited: 67

more ...

less ...

Background

education and training

B.A., University of Chicago 73
M.D., Harvard Medical School 1977

Contact

full name

Ellin Berman

VIVO Weill Cornell Medical College

Ellin Berman Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name